Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD and pre-BTD overview

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Oct 10, 2023 2:54pm

184 Views

Post# 35677513

RE:RE:RE:BTD and pre-BTD overview

I think the PreBTD Is some form of explanation that ir is still Work in progress. I get it that FDA is not an easy organisation to work without a Lobbyist who is well versed in this area. TLT Keeps moving their target dates at the expense of credibility. Hopefully we are very close to BTD and AA.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario